Skip to Main Content

A few dozen groups representing patients, providers, and consumers are asking insurance commissioners across the U.S. to investigate the growing use of copay accumulators — a new weapon against widely used but controversial copay assistance that drug makers offer to consumers.

These have been embraced by a growing number of insurers and employers to keep down drug costs because accumulators do not count the value of any co-pay assistance cards or coupons toward out-of-pocket medicine costs that are applied toward deductibles.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!